Surgery is the mainstay of therapy for early-stage<unk><unk> . Surgical procedure selection will depend on the histology, margins, and size of the<unk> . Common surgical procedures for the treatment of<unk><unk>  include lung resection with lobectomy, lung resection with pneumonectomy with or without lymph node dissection, thoracotomy with the removal of the entire lung or lobe (lobectomy) along with regional lymph nodes (peribronchial and perihilar lymph node dissection), and pathological evaluation. If evidence of lymph node extension of the disease is present adjuvant chemotherapy should be administered. Surgical resection is not recommended for patients with advanced or metastatic lung carcinoma. Surgical staging of the mediastinum is considered standard if accurate evaluation of the nodal status is needed to determine therapy. Surgical treatment consists of a thoracotomy with removal of the entire lung or lobe along with regional lymph nodes and contiguous structures. Pneumonectomy is used if the<unk>  involves the main bronchus, extends across a fissure or is located such that wide excision is required. Survival following ‘curative’ resection is approximately 30% at 5 years and 15% at 10 years. The best results are found in squamous cell carcinoma followed by large-cell carcinoma and the adenocarcinoma. If the<unk>  is inoperable, stereotactic ablative radiation therapy should be administered.
Pancoast tumor surgery
Thymoma surgery
Lung cancer surgery
Tuberculosis surgery
Mast cell leukemia surgery
Nasopharyngeal carcinoma surgery
Hypopharyngeal cancer surgery
Bronchogenic cyst surgery